That is published clinical trial data - not marketing language - and your provider can discuss what it means for your specific situation
First, compared to the LC-MS/MS bioanalytical methods for small molecule drugs, the sample preparation process for peptide/protein drugs is often more complex
Two patients may require different compounds or doses based on their peptide-pathway genetics, yet the clinical community rarely tests for these differences before initiating treatment
However, the transition will likely occur gradually rather than overnight
However, you might have a special patientlike a diabetic who's on opioid pain medicines or also has Parkinsons diseasethat might have two or three reasons for having gastroparesis, which would obviously put them more at risk
While the medication provides powerful metabolic effects, combining it with evidence-based lifestyle modifications significantly enhances outcomes and promotes long-term success